Highly robust and optimized conjugation of antibodies to nanoparticles using quantitatively validated protocols

Area of Science:

• Bioconjugation Chemistry
• Nanotechnology
• Biomedical Diagnostics

Background:

• Antibody-conjugated nanoparticles (NPs) are crucial for sensitive bioassays and targeted therapies.
• Current conjugation methods face challenges in efficiency, antibody orientation, and denaturation.
• Optimizing antibody density and orientation on NPs is critical for quantitative bioassays.

Purpose of the Study:

• To develop a versatile and oriented antibody conjugation method for NPs.
• To quantitatively evaluate the impact of conjugation strategy on antibody binding capacity.
• To demonstrate the broad applicability of the developed conjugation technique.

Main Methods:

• Utilized copper-free click chemistry for oriented antibody conjugation to NPs.
• Quantitatively assessed the number of conjugated antibodies using fluorescent labeling.
• Experimentally evaluated the binding capacity of antibody-conjugated NPs against target antigens.
• Compared the developed method with the traditional EDC/NHS coupling method.

Main Results:

• The copper-free click chemistry method achieved oriented antibody conjugation.
• Binding capacity of antibody-conjugated NPs was 8 times superior to EDC/NHS coupling.
• Demonstrated versatility by conjugating antibodies to three types of silica-encapsulated NPs.
• Quantitative evaluation confirmed improved antibody density and binding function.

Conclusions:

• Copper-free click chemistry offers a superior strategy for antibody-NP conjugation.
• The developed method enhances NP targeting efficacy and bioassay performance.
• This versatile approach holds significant potential for advanced diagnostics and therapeutics.